Article,

Primary endpoints for randomised trials of cancer therapy.

.
Lancet, 371 (9631): 2156-8 (June 2008)4589<m:linebreak></m:linebreak>PUBM: Print; JID: 2985213R; 0 (Aromatase Inhibitors); ppublish;<m:linebreak></m:linebreak>Mesures de resultats.
DOI: 10.1016/S0140-6736(08)60933-2

Meta data

Tags

Users

  • @jepcastel

Comments and Reviews